Brief: India's Natco Pharma Reports Profit For March-Qtr
May 29 (Reuters) - Natco Pharma Ltd NATP.NS :
* INDIA'S NATCO PHARMA LTD MARCH-QUARTER CONSOL NET PROFIT
2.76
BILLION RUPEES VERSUS LOSS 505 MILLION RUPEES
* NATCO PHARMA LTD MARCH-QUARTER CONSOL REVENUE FROM
OPERATIONS
8.98 BILLION RUPEES VERSUS 5.97 BILLION RUPEES
* APPROVED INCORPORATION OF UNIT IN COLOMBIA WITH AN
INVESTMENT UP
TO $100,000
* TO ACQUIRE ZISTA PHARMA FOR $2 -3 MILLION
Source text for Eikon: ID:nBSE8W23mR
Further company coverage: NATP.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees